UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20655) 20655
Book Chapter (287) 287
Dissertation (99) 99
Book / eBook (80) 80
Magazine Article (69) 69
Publication (23) 23
Conference Proceeding (17) 17
Government Document (13) 13
Web Resource (6) 6
Journal / eJournal (4) 4
Poster (4) 4
Book Review (1) 1
Newsletter (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18125) 18125
science & technology (13838) 13838
life sciences & biomedicine (13555) 13555
female (12260) 12260
antineoplastic agents, hormonal - therapeutic use (10309) 10309
middle aged (6891) 6891
oncology (6701) 6701
male (6493) 6493
breast neoplasms - drug therapy (5913) 5913
aged (5794) 5794
adult (4911) 4911
breast cancer (4193) 4193
treatment outcome (3480) 3480
tamoxifen - therapeutic use (3273) 3273
prostatic neoplasms - drug therapy (3053) 3053
antineoplastic agents, hormonal - adverse effects (2921) 2921
antineoplastic agents, hormonal - administration & dosage (2746) 2746
cancer (2617) 2617
breast neoplasms - pathology (2540) 2540
tamoxifen (2420) 2420
aged, 80 and over (2372) 2372
prostate cancer (2318) 2318
antineoplastic agents, hormonal - pharmacology (2243) 2243
chemotherapy, adjuvant (2226) 2226
care and treatment (2202) 2202
risk factors (1945) 1945
animals (1793) 1793
prognosis (1740) 1740
obstetrics & gynecology (1636) 1636
prostatic neoplasms - pathology (1624) 1624
antineoplastic combined chemotherapy protocols - therapeutic use (1621) 1621
abridged index medicus (1607) 1607
hormonal therapy (1572) 1572
health aspects (1530) 1530
androgen antagonists - therapeutic use (1524) 1524
combined modality therapy (1491) 1491
medicine & public health (1472) 1472
neoplasm staging (1463) 1463
breast neoplasms - metabolism (1438) 1438
retrospective studies (1393) 1393
disease-free survival (1353) 1353
urology & nephrology (1346) 1346
follow-up studies (1323) 1323
research (1318) 1318
chemotherapy (1290) 1290
time factors (1282) 1282
postmenopause (1170) 1170
tamoxifen - adverse effects (1160) 1160
menopause (1148) 1148
analysis (1116) 1116
endocrinology & metabolism (1114) 1114
estrogen (1066) 1066
breast neoplasms - genetics (1032) 1032
drug therapy (1029) 1029
survival analysis (1012) 1012
prostate-specific antigen - blood (1009) 1009
prospective studies (997) 997
drug resistance, neoplasm (979) 979
tamoxifen - pharmacology (978) 978
general & internal medicine (967) 967
receptors, estrogen - metabolism (967) 967
medicine, general & internal (955) 955
breast neoplasms - surgery (945) 945
randomized controlled trials as topic (943) 943
pharmacology & pharmacy (939) 939
breast neoplasms - mortality (924) 924
surgery (914) 914
prostatic neoplasms - therapy (902) 902
tamoxifen - administration & dosage (898) 898
survival rate (887) 887
aromatase inhibitors - therapeutic use (885) 885
quality of life (861) 861
adolescent (860) 860
neoplasms, hormone-dependent - drug therapy (845) 845
endocrine therapy (843) 843
contraceptives, oral, hormonal - adverse effects (833) 833
cell line, tumor (827) 827
hormones (819) 819
disease progression (801) 801
drug administration schedule (767) 767
breast neoplasms - therapy (753) 753
clinical trials as topic (750) 750
antineoplastic agents - therapeutic use (748) 748
metastasis (745) 745
nitriles - therapeutic use (734) 734
octreotide - therapeutic use (733) 733
hematology, oncology and palliative medicine (729) 729
radiotherapy (715) 715
prostatic neoplasms - mortality (707) 707
adenocarcinoma - drug therapy (704) 704
estrogens (704) 704
aromatase inhibitors (697) 697
mice (690) 690
prostatic neoplasms - radiotherapy (689) 689
prostatic neoplasms - blood (682) 682
pregnancy (676) 676
triazoles - therapeutic use (668) 668
risk assessment (664) 664
young adult (657) 657
immunohistochemistry (652) 652
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (38) 38
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
UofT at Mississauga - Stacks (4) 4
New College (Ivey) - Stacks (3) 3
St. Michael's Hospital - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Mt Sinai Hospital - Online (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19139) 19139
French (615) 615
Japanese (470) 470
German (431) 431
Spanish (296) 296
Russian (205) 205
Portuguese (195) 195
Italian (162) 162
Polish (104) 104
Chinese (87) 87
Czech (62) 62
Hungarian (59) 59
Dutch (31) 31
Danish (25) 25
Bulgarian (22) 22
Norwegian (16) 16
Swedish (13) 13
Finnish (12) 12
Croatian (11) 11
Korean (11) 11
Serbian (11) 11
Romanian (9) 9
Slovak (9) 9
Hebrew (4) 4
Ukrainian (4) 4
Turkish (3) 3
Bosnian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Estonian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 08/2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast cancer... 
early breast cancer | systemic adjuvant therapies | St Gallen Consensus | radiation therapy | surgery | Radiation therapy | Early breast cancer | Systemic adjuvant therapies | Surgery | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Index Medicus | Special
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 11/2009, Volume 27, Issue 33, pp. 5538 - 5546
Purpose Cross-talk between human epidermal growth factor receptors and hormone receptor pathways may cause endocrine resistance in breast cancer. This trial... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Postmenopause - drug effects | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma - pathology | Carcinoma - secondary | Carcinoma - drug therapy | Receptors, Estrogen - genetics | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Biomarkers, Tumor - analysis | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Breast Neoplasms - pathology | Quinazolines - adverse effects | Survival Analysis | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasm Staging | Nitriles - adverse effects | Index Medicus | Carcinoma | Quinazolines | Breast Neoplasms | Life Sciences | Immunology | Triazoles | Postmenopause | Nitriles | Antineoplastic Agents, Hormonal | Tumor Markers, Biological | Receptors, Estrogen | Neoplasm Invasiveness | Antineoplastic Combined Chemotherapy Protocols | Receptor, erbB-2 | Receptors, Progesterone | Kaplan-Meiers Estimate
Journal Article
2005, 1, ISBN 0520221516, 381
.... This provocative book investigates the complex, bizarre, and sometimes outrageous history of synthetic testosterone and other male hormone therapies... 
Testosterone | Hormone therapy | Sociology | Menopause | Rejuvenation | Longevity | Aphrodisiacs | Physiological effect | Therapeutic use | Hormone Replacement Therapy | trends | Doping in Sports
Book
Journal Article